Theralizumab, CAS [[906068-56-2]]

Produktübersicht

• Artikelname: Theralizumab, CAS [[906068-56-2]]
• Artikelnummer: TGM-T77093
• Hersteller Artikelnummer: T77093
• Alternativnummer: TGM-T77093-1MG,TGM-T77093-5MG,TGM-T77093-10MG,TGM-T77093-25MG,TGM-T77093-50MG
• Hersteller: TargetMol
• Kategorie: Biochemikalien
• Alternative Synonym: TGN1412 , TAB-08 , TABO8

Produktbeschreibung

Theralizumab (TGN1412) is an anti-CD28-targeting monoclonal antibody that directly stimulates T cells. Theralizumab has antitumor activity and is used for the treatment of B-cell chronic lymphocytic leukemia and rheumatoid arthritis.

Produkteigenschaften

• Reinheit: 95.00%
• CAS Nummer: [906068-56-2]
• Target-Kategorie: Immunology/Inflammation related|||Others